Skip to content
Screener

AtriCure ATRC Total Revenue

Discontinued — last reported Q2 '26

Total Revenue at other companies

Abbott logo
AbbottABT
$12.59B+13.0%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$25.31B+6.6%
Boston Scientific logo
Boston ScientificBSX
$5.44B+7.5%
Medtronic logo
MedtronicMDT
$9.81B+9.9%
ITG
Integer HoldingsITGR
$439.58M+0.5%
AngioDynamics logo
AngioDynamicsANGO
$86.61M+8.0%

Segments

By geography

See full
Total International$28.02M+9.6%
Europe$17.21M+6.7%
Asia Pacific$8.63M+15.4%
Other International$2.17M+12.1%

By product

See full
Appendage management$63.99M+14.4%
Open ablation$52.13M+11.3%
Pain management$29.44M+26.9%
Minimally invasive ablation$8.05M-21.2%

Other financials

Income statement

See full
Gross profit$118.6M+16.9%
Operating income$9.7M+256%
Net income$9.0M+245%
EPS (diluted)$0.18+238%

Balance sheet

See full
Cash & equivalents$167.8M+42.4%
Total debt$75.5M-3.8%
Total equity$516.4M+11.2%
Total assets$676.6M+11.1%

Cash flow

See full
Operating cash flow$22.2M+2.7%
CapEx$3.8M+41.5%
Free cash flow$18.4M-2.8%

Valuation

See full
Market cap$2.01B+10.7%
Enterprise value$1.92B+7.9%
P/E770.8×
P/S3.5×-0.1×

Profitability

See full
Gross margin76.3%+1.6pp
Operating margin-5.1%-1.3pp
Net margin-5.6%-1.5pp
FCF margin9.3%

Returns & leverage

See full
Return on equity-6.1%-1.3pp
Debt / equity0.1×0.0×
Current ratio4.2×+0.3×

Where this comes from

Reported directly by AtriCure in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: AtriCure’s 10-Q, filed July 27, 2026.

Filed
Jul 27, 2026, 1:07 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001323885-26-000035
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Revenue$153,604$136,139$294,853$259,759
Cost of revenue34,97534,65766,91365,649
Gross profit118,629101,482227,940194,110
Operating expenses:
Research and development expenses26,40229,28450,63751,812
Selling, general and administrative expenses82,56278,390167,112154,444
Total operating expenses108,964107,674217,749206,256
Income (loss) from operations9,665(6,192)10,191(12,146)

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is AtriCure's total revenue?
AtriCure (ATRC) reported total revenue of $153.6M in Q2 2026.
How has AtriCure's total revenue changed year-over-year?
AtriCure's total revenue increased by 12.8% year-over-year, from $136.14M to $153.6M.
What is the long-term trend for AtriCure's total revenue?
Over 4 years (2021 to 2025), AtriCure's total revenue has grown at a 18.1% compound annual growth rate (CAGR), from $274.33M to $534.53M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about AtriCure's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude